Finopan-D Capsule PR is a combination medication containing Domperidone 30mg and Pantoprazole 40mg, formulated to provide effective relief from gastrointestinal disorders. Domperidone is a dopamine antagonist that enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby reducing symptoms such as nausea, vomiting, bloating, and discomfort associated with delayed gastric emptying. Pantoprazole, a proton pump inhibitor, works by suppressing gastric acid secretion, promoting healing of acid-related damage in the stomach and esophagus, and providing symptomatic relief from conditions like gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The combination of these two active ingredients in Finopan-D Capsule PR offers a synergistic approach to managing upper gastrointestinal symptoms by addressing both motility and acid secretion. This medication is typically prescribed for patients experiencing symptoms of acid reflux, indigestion, and gastroparesis. It is important to use Finopan-D Capsule PR under medical supervision, as it may have contraindications and potential interactions with other drugs. Patients should follow the prescribed dosage and report any adverse effects such as headache, dry mouth, or allergic reactions to their healthcare provider promptly.